Tag: biologic bone graft

financing

Use of i-FACTOR peptide enhanced bone graft more than doubles fusion...

The use of i-FACTOR peptide enhanced bone graft (Cerapedics) resulted in a 50% fusion rate, compared to a 20% fusion rate using allograft in...

Cerapedics receives FDA approval to initiate IDE study of P-15L bone...

Cerapedics, a privately-held orthobiologics company, has announced the company received approval from the US Food and Drug Administration (FDA) to initiate an investigational device...
I-factor peptide-enhanced bone graft

Peptide-enhanced bone graft outperforms autograft at two years

A prospective, multicentre trial has found that a peptide-enhanced bone graft is non-inferior compared to local autograft bone. In addition, the bone graft outperformed...